MICROBOT MEDICAL INC. - COMMON STOCK

Microbot Medical Announces $2.66 Million Registered Direct Offering of Common Stock Priced At-The-Market under Nasdaq Rules

23 май 2023 14:24:08 Источник Nasdaq GlobeNewswire

Microbot Medical Announces Closing of $1.4 Million Registered Direct Offering of Common Stock Priced At-The-Market under Nasdaq Rules

23 май 2023 12:41:00 Источник Nasdaq GlobeNewswire

Microbot Medical Announces $1.4 Million Registered Direct Offering of Common Stock Priced At-The-Market under Nasdaq Rules

22 май 2023 14:18:00 Источник Nasdaq GlobeNewswire

Microbot Medical Achieved 100% Success Rate for LIBERTY in Extensive Pre-Clinical Animal Study Performed by Leading European Physicians

22 май 2023 07:30:00 Источник Nasdaq GlobeNewswire

Microbot Medical to Enhance Focus on its Core Business and Prioritize Preparations for Regulatory and First in Human Clinical Cases

18 май 2023 08:15:00 Источник Nasdaq GlobeNewswire

Microbot Medical Initiates Preparations for First-In-Human (FIH) Cases in Brazil for the LIBERTY® Robotic System

08 май 2023 07:30:00 Источник Nasdaq GlobeNewswire

Microbot Medical Announces Final Data From Its Recent Animal Study

05 май 2023 08:00:00 Источник Nasdaq GlobeNewswire

Microbot Medical’s LIBERTY® Robotic System Surpasses 100th Catheterization

03 май 2023 08:00:01 Источник Nasdaq GlobeNewswire

Gerry O’Sullivan, the Latest Member to Join Microbot Medical’s Scientific Advisory Board, to Leverage Extensive Interventional Radiology Experience to Progress the LIBERTY® Robotic System Through Regulatory, Clinical and Commercialization Phases

23 мар 2023 08:00:00 Источник Nasdaq GlobeNewswire

Microbot Medical Launches Presence in the United Kingdom as Highly Accomplished Consultant Interventional Radiologist Professor Mark W. Little Joins its Scientific Advisory Board as Efforts to Commercialize the LIBERTY® Robotic System Continue to Accelerate

16 мар 2023 08:00:00 Источник Nasdaq GlobeNewswire

Microbot Medical Increases Presence in the EU with the Addition of Greece-based Key Opinion Leader Stavros Spiliopoulos, MD, PhD, EBIR-ES, FCIRSE, to its Scientific Advisory Board

13 мар 2023 08:00:00 Источник Nasdaq GlobeNewswire

Microbot Medical’s Chief Medical Officer Dr. Eyal Morag to Highlight Performance, Safety and Usability Benefits of the LIBERTY® Robotic System During Podium Presentation at Prestigious Robotics Conference

09 мар 2023 08:00:01 Источник Nasdaq GlobeNewswire

Microbot Medical Leverages Recently Awarded Non-Dilutive Grant from the Israeli Government to Promote Marketing Activities Toward Commercialization of the LIBERTY® Robotic System

02 мар 2023 08:00:00 Источник Nasdaq GlobeNewswire

Microbot Medical Meeting with Key Opinion Leaders, Hospital Administrators, and Potential Strategic and Commercial Partners at the Society of Interventional Radiologist Annual Meeting

28 фев 2023 08:00:01 Источник Nasdaq GlobeNewswire

Microbot Medical Expands its Geographic Presence to South America with the Addition of Francisco C. Carnevale, MD, PhD, FSIR to its Scientific Advisory Board

27 фев 2023 08:00:00 Источник Nasdaq GlobeNewswire

Microbot Medical’s Remote Controller for the LIBERTY® Robotic System Receives Design Patent Allowance in Japan

23 фев 2023 07:00:02 Источник Nasdaq GlobeNewswire

Microbot Medical Welcomes Distinguished Interventional Cardiologist and Early Adopter of Endovascular Robotics to its Next “Access-Ability Live by MBOT” Webinar Series

31 янв 2023 06:30:00 Источник Nasdaq GlobeNewswire

Microbot Medical Announces MedTech Industry Veteran Joe Mullings will Moderate the Next ‘Access-Ability Live by MBOT’ Webinar

06 янв 2023 06:00:00 Источник Nasdaq GlobeNewswire

Microbot Medical Announces the Participation of a Key Opinion Leader in the Endovascular Robotics Space at the Next “Access-Ability Live by MBOT” Webinar Series

14 дек 2022 07:30:00 Источник Nasdaq GlobeNewswire

Microbot Medical’s Proprietary LIBERTY® Robotic System Receives Third Patent Allowance in Israel

08 дек 2022 06:00:00 Источник Nasdaq GlobeNewswire